BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin CJ, Gong HY, Tseng HC, Wang WL, Wu JL. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun. 2008;375:315-320. [PMID: 18692484 DOI: 10.1016/j.bbrc.2008.07.154] [Cited by in Crossref: 180] [Cited by in F6Publishing: 178] [Article Influence: 12.9] [Reference Citation Analysis]
Number Citing Articles
1 Chun K. Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma. Pharmaceutics 2022;14:1380. [DOI: 10.3390/pharmaceutics14071380] [Reference Citation Analysis]
2 Szczepanek J, Skorupa M, Tretyn A. MicroRNA as a Potential Therapeutic Molecule in Cancer. Cells 2022;11:1008. [PMID: 35326459 DOI: 10.3390/cells11061008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu Y, Yang H, Liu Q, Pan M, Wang D, Pan S, Zhang W, Wei J, Zhao X, Ji J. Selenocystine-Derived Label-Free Fluorescent Schiff Base Nanocomplex for siRNA Delivery Synergistically Kills Cancer Cells. Molecules 2022;27:1302. [PMID: 35209090 DOI: 10.3390/molecules27041302] [Reference Citation Analysis]
4 Muhammad M, Shao CS, Liu C, Huang Q. Highly Sensitive Detection of Elevated Exosomal miR-122 Levels in Radiation Injury and Hepatic Inflammation Using an Aptamer-Functionalized SERS-Sandwich Assay. ACS Appl Bio Mater 2021;4:8386-95. [PMID: 35005951 DOI: 10.1021/acsabm.1c00845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Choi JY, Seok HJ, Kim RK, Choi MY, Lee SJ, Bae IH. miR-519d-3p suppresses tumorigenicity and metastasis by inhibiting Bcl-w and HIF-1α in NSCLC. Mol Ther Oncolytics 2021;22:368-79. [PMID: 34553025 DOI: 10.1016/j.omto.2021.06.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Qin S, Xu J, Yi Y, Jiang S, Jin P, Xia X, Ma F. Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma. Front Oncol 2021;11:691115. [PMID: 34307154 DOI: 10.3389/fonc.2021.691115] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Chen C, Deng L, Nie DK, Jia F, Fu LS, Wan ZQ, Lan Q. Circular RNA Pleiotrophin promotes carcinogenesis in glioma via regulation of microRNA-122/SRY-box transcription factor 6 axis. Eur J Cancer Prev 2020;29:165-73. [PMID: 31609809 DOI: 10.1097/CEJ.0000000000000535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
8 Zhang H, Liu S, Chen L, Sheng Y, Luo W, Zhao G. MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma. Bioengineered 2021;12:2263-73. [PMID: 34115554 DOI: 10.1080/21655979.2021.1932210] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Ge X, Xie H, Wang L, Li R, Zhang F, Xu J, Zhao B, Du J. MicroRNA-122 promotes apoptosis of keratinocytes in oral lichen planus through suppressing VDR expression. J Cell Mol Med 2021;25:3400-7. [PMID: 33656264 DOI: 10.1111/jcmm.16418] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers (Basel) 2021;13:514. [PMID: 33572780 DOI: 10.3390/cancers13030514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
11 Chou KY, Chang AC, Tsai TF, Lin YC, Chen HE, Ho CY, Chen PC, Hwang TI. MicroRNA‑34a‑5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase‑2 silencing. Oncol Rep 2021;45:911-20. [PMID: 33650650 DOI: 10.3892/or.2020.7910] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
12 Yang Z, Wu W, Ou P, Wu M, Zeng F, Zhou B, Wu S. MiR-122-5p knockdown protects against APAP-mediated liver injury through up-regulating NDRG3. Mol Cell Biochem 2021;476:1257-67. [PMID: 33247804 DOI: 10.1007/s11010-020-03988-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
13 Karbasforooshan H, Hayes AW, Mohammadzadeh N, Zirak MR, Karimi G. The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy. Cell Cycle 2020;19:3209-21. [PMID: 33164623 DOI: 10.1080/15384101.2020.1843813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Gupta M, Chandan K, Sarwat M. Role of microRNA and Long Non-Coding RNA in Hepatocellular Carcinoma. Curr Pharm Des 2020;26:415-28. [PMID: 31939724 DOI: 10.2174/1381612826666200115093835] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
15 Fang Q, Liao Y, Xu Z, Li J, Zhang X, Wang Y. The diagnostic value of circulating microRNAs as biomarkers for coronary artery disease: A meta‑analysis. Anatol J Cardiol 2020;24:290-9. [PMID: 33122485 DOI: 10.14744/AnatolJCardiol.2020.91582] [Reference Citation Analysis]
16 Hsu K, Wei C, Su Y, Chou T, Lin Y, Yang F, Tsou A, Hsu C, Tseng P, Chen N, Jeng K, Leu C. Upregulation of RelB in the miR-122 knockout mice contributes to increased levels of proinflammatory chemokines/cytokines in the liver and macrophages. Immunology Letters 2020;226:22-30. [DOI: 10.1016/j.imlet.2020.06.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wang T, Liu Z, Wang X, Bai P, Sun A, Shao Z, Luo R, Wu Z, Zhang K, Li W, Xiao W, Duan B, Wang Y, Chen B, Xing J. Identification of potential therapeutic targets in urothelial bladder carcinoma of Chinese population by targeted next-generation sequencing. Cancer Biol Ther 2020;21:709-16. [PMID: 32449441 DOI: 10.1080/15384047.2020.1763148] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Xu J, An P, Winkler CA, Yu Y. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets. Front Oncol. 2020;10:1271. [PMID: 32850386 DOI: 10.3389/fonc.2020.01271] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
19 Sartorius K, Swadling L, An P, Makarova J, Winkler C, Chuturgoon A, Kramvis A. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways. Viruses 2020;12:E746. [PMID: 32664401 DOI: 10.3390/v12070746] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
20 Li J, Jin B, Wang T, Li W, Wang Z, Zhang H, Song Y, Li N. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. Cancer Biomark 2019;26:501-12. [PMID: 31658041 DOI: 10.3233/CBM-181970] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 8.5] [Reference Citation Analysis]
21 Finocchi F, Pelloni M, Balercia G, Pallotti F, Radicioni AF, Lenzi A, Lombardo F, Paoli D. Seminal plasma miRNAs in Klinefelter syndrome and in obstructive and non-obstructive azoospermia. Mol Biol Rep 2020;47:4373-82. [DOI: 10.1007/s11033-020-05552-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Hartman ML, Czyz M. BCL-w: apoptotic and non-apoptotic role in health and disease. Cell Death Dis 2020;11:260. [PMID: 32317622 DOI: 10.1038/s41419-020-2417-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
23 Zhang S, Zhou Y, Wang Y, Wang Z, Xiao Q, Zhang Y, Lou Y, Qiu Y, Zhu F. The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years. Brief Bioinform 2021;22:1860-83. [PMID: 32249290 DOI: 10.1093/bib/bbaa023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
24 Varghese RS, Zhou Y, Barefoot M, Chen Y, Di Poto C, Balla AK, Oliver E, Sherif ZA, Kumar D, Kroemer AH, Tadesse MG, Ressom HW. Identification of miRNA-mRNA associations in hepatocellular carcinoma using hierarchical integrative model. BMC Med Genomics 2020;13:56. [PMID: 32228601 DOI: 10.1186/s12920-020-0706-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhao XF, Li N, Lin DD, Sun LB. Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis. Biomed Res Int. 2020;2020:5353695. [PMID: 32309434 DOI: 10.1155/2020/5353695] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
26 Wang S, Yang Y, Sun L, Qiao G, Song Y, Liu B. Exosomal MicroRNAs as Liquid Biopsy Biomarkers in Hepatocellular Carcinoma. Onco Targets Ther. 2020;13:2021-2030. [PMID: 32210570 DOI: 10.2147/ott.s232453] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
27 Salomão KB, Pezuk JA, de Souza GR, Chagas P, Pereira TC, Valera ET, Brassesco MS. MicroRNA dysregulation interplay with childhood abdominal tumors. Cancer Metastasis Rev 2019;38:783-811. [PMID: 31848768 DOI: 10.1007/s10555-019-09829-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
28 Zhang J, Xu X, Huang X, Zhu H, Chen H, Wang W, Liu Y. Analysis of microRNA expression profiles in porcine PBMCs after LPS stimulation. Innate Immun 2020;26:435-46. [PMID: 31969027 DOI: 10.1177/1753425920901560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Cheng Q, Wang L. LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p. Cell Cycle 2020;19:290-9. [PMID: 31914881 DOI: 10.1080/15384101.2019.1707454] [Cited by in Crossref: 13] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
30 Elhefnawi M, Salah Z, Soliman B. The Promise of miRNA Replacement Therapy for Hepatocellular Carcinoma. CGT 2019;19:290-304. [DOI: 10.2174/1566523219666191023101433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Wang H, Lu Z, Zhao X. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer. J Hematol Oncol. 2019;12:133. [PMID: 31815633 DOI: 10.1186/s13045-019-0806-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 81] [Article Influence: 11.0] [Reference Citation Analysis]
32 Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, Kramvis A. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019;8:E1504. [PMID: 31771261 DOI: 10.3390/cells8121504] [Cited by in Crossref: 23] [Cited by in F6Publishing: 32] [Article Influence: 7.7] [Reference Citation Analysis]
33 Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. World J Gastroenterol 2019; 25(42): 6322-6341 [PMID: 31754293 DOI: 10.3748/wjg.v25.i42.6322] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
34 Ha SY, Yu JI, Choi C, Kang SY, Joh JW, Paik SW, Kim S, Kim M, Park HC, Park CK. Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma. Sci Rep 2019;9:14738. [PMID: 31611609 DOI: 10.1038/s41598-019-50594-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
35 Li XN, Yang H, Yang T. miR-122 Inhibits Hepatocarcinoma Cell Progression by Targeting LMNB2. Oncol Res 2020;28:41-9. [PMID: 31558184 DOI: 10.3727/096504019X15615433287579] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
36 Shi L, Zheng X, Fan Y, Yang X, Li A, Qian J. The contribution of miR-122 to the innate immunity by regulating toll-like receptor 4 in hepatoma cells. BMC Gastroenterol 2019;19:130. [PMID: 31340754 DOI: 10.1186/s12876-019-1048-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
37 Wang D, Sun X, Wei Y, Liang H, Yuan M, Jin F, Chen X, Liu Y, Zhang CY, Li L, Zen K. Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level. Nucleic Acids Res 2018;46:2012-29. [PMID: 29253196 DOI: 10.1093/nar/gkx1254] [Cited by in Crossref: 24] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
38 Li Y, Yang N, Dong B, Yang J, Kou L, Qin Q. MicroRNA-122 promotes endothelial cell apoptosis by targeting XIAP: Therapeutic implication for atherosclerosis. Life Sci 2019;232:116590. [PMID: 31228514 DOI: 10.1016/j.lfs.2019.116590] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
39 Bhuckory S, Kays JC, Dennis AM. In Vivo Biosensing Using Resonance Energy Transfer. Biosensors (Basel) 2019;9:E76. [PMID: 31163706 DOI: 10.3390/bios9020076] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
40 Heydari Z, Rahaie M, Alizadeh AM. Different anti-inflammatory effects of Lactobacillus acidophilus and Bifidobactrum bifidioum in hepatocellular carcinoma cancer mouse through impact on microRNAs and their target genes. Journal of Nutrition & Intermediary Metabolism 2019;16:100096. [DOI: 10.1016/j.jnim.2019.100096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
41 Starlinger P, Hackl H, Pereyra D, Skalicky S, Geiger E, Finsterbusch M, Tamandl D, Brostjan C, Grünberger T, Hackl M, Assinger A. Predicting Postoperative Liver Dysfunction Based on Blood-Derived MicroRNA Signatures. Hepatology 2019;69:2636-51. [PMID: 30779441 DOI: 10.1002/hep.30572] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
42 Xuan Z, Feng X, Yu J, Ping P, Zhao H, Zhu X, Wang L. A Novel Method for Predicting Disease-Associated LncRNA-MiRNA Pairs Based on the Higher-Order Orthogonal Iteration. Comput Math Methods Med 2019;2019:7614850. [PMID: 31191710 DOI: 10.1155/2019/7614850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
43 Zhang Y, Li Y, Jiang W, Li Q, Lan Y. The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset. Medicine (Baltimore) 2019;98:e14810. [PMID: 30921182 DOI: 10.1097/MD.0000000000014810] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
44 Fan R, Xiao C, Wan X, Cha W, Miao Y, Zhou Y, Qin C, Cui T, Su F, Shan X. Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics. RNA Biol 2019;16:707-18. [PMID: 30900502 DOI: 10.1080/15476286.2019.1593094] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
45 Kalantari H, Asadmasjedi N, Abyaz MR, Mahdavinia M, Mohammadtaghvaei N. Protective effect of inulin on methotrexate- induced liver toxicity in mice. Biomedicine & Pharmacotherapy 2019;110:943-50. [DOI: 10.1016/j.biopha.2018.11.144] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
46 Bei C, Liu S, Yu X, Qiu M, Tang B, Liao W, He S, Yu H. Single Nucleotide Polymorphisms in miR-122 Are Associated with the Risk of Hepatocellular Carcinoma in a Southern Chinese Population. Biomed Res Int 2018;2018:1540201. [PMID: 30662901 DOI: 10.1155/2018/1540201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Sadri Nahand J, Bokharaei-Salim F, Salmaninejad A, Nesaei A, Mohajeri F, Moshtzan A, Tabibzadeh A, Karimzadeh M, Moghoofei M, Marjani A, Yaghoubi S, Keyvani H. microRNAs: Key players in virus-associated hepatocellular carcinoma. J Cell Physiol 2019;234:12188-225. [PMID: 30536673 DOI: 10.1002/jcp.27956] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
48 Swier LJYM, Dzikiewicz-Krawczyk A, Winkle M, van den Berg A, Kluiver J. Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer. Mol Oncol 2019;13:26-45. [PMID: 30451365 DOI: 10.1002/1878-0261.12409] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
49 Whitmill A, Kim S, Rojas V, Gulraiz F, Afreen K, Jain M, Singh M, Park IW. Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection. PLoS One 2018;13:e0202524. [PMID: 30138348 DOI: 10.1371/journal.pone.0202524] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
50 Ren H, Long Z, Shen X, Zhang Y, Sun J, Ouyang J, Na N. Sandwich DNA Hybridization Fluorescence Resonance Energy-Transfer Strategy for miR-122 Detection by Core-Shell Upconversion Nanoparticles. ACS Appl Mater Interfaces 2018;10:25621-8. [PMID: 29969017 DOI: 10.1021/acsami.8b03429] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
51 Andaur R, Tapia JC, Moreno J, Soto L, Armisen R, Marcelain K. Differential miRNA expression profiling reveals miR-205-3p to be a potential radiosensitizer for low- dose ionizing radiation in DLD-1 cells. Oncotarget 2018;9:26387-405. [PMID: 29899866 DOI: 10.18632/oncotarget.25405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
52 Zekri AN, El-Sisi ER, Youssef ASE, Kamel MM, Nassar A, Ahmed OS, El Kassas M, Barakat AB, Abd El-Motaleb AI, Bahnassy AA. MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection. PLoS One 2018;13:e0193709. [PMID: 29534065 DOI: 10.1371/journal.pone.0193709] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
53 Tsai TF, Lin JF, Chou KY, Lin YC, Chen HE, Hwang TI. miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells. Onco Targets Ther 2018;11:239-52. [PMID: 29379304 DOI: 10.2147/OTT.S114276] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
54 Guan Y, Rao Z, Chen C. miR-30a suppresses lung cancer progression by targeting SIRT1. Oncotarget 2018;9:4924-34. [PMID: 29435152 DOI: 10.18632/oncotarget.23529] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
55 Cha W, Fan R, Miao Y, Zhou Y, Qin C, Shan X, Wan X, Cui T. MicroRNAs as novel endogenous targets for regulation and therapeutic treatments. Medchemcomm 2018;9:396-408. [PMID: 30108932 DOI: 10.1039/c7md00285h] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
56 Fan Y, Ma X, Li H, Gao Y, Huang Q, Zhang Y, Bao X, Du Q, Luo G, Liu K, Meng Q, Zhao C, Zhang X. miR-122 promotes metastasis of clear-cell renal cell carcinoma by downregulating Dicer. Int J Cancer 2018;142:547-60. [PMID: 28921581 DOI: 10.1002/ijc.31050] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
57 Guo M, Zhao X, Yuan X, Li P. Elevated microRNA-34a contributes to trophoblast cell apoptosis in preeclampsia by targeting BCL-2. J Hum Hypertens 2017;31:815-20. [PMID: 29022890 DOI: 10.1038/jhh.2017.65] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
58 Lin Y, Lin J, Tsai T, Chou K, Chen H, Hwang TI. Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells. Asian Journal of Surgery 2017;40:396-406. [DOI: 10.1016/j.asjsur.2016.07.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 52] [Article Influence: 7.8] [Reference Citation Analysis]
59 van der Ree MH, Stelma F, Willemse SB, Brown A, Swadling L, van der Valk M, Sinnige MJ, van Nuenen AC, de Vree JML, Klenerman P, Barnes E, Kootstra NA, Reesink HW. Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing. Antiviral Res 2017;146:139-45. [PMID: 28844749 DOI: 10.1016/j.antiviral.2017.08.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
60 Demerdash HM, Hussien HM, Hassouna E, Arida EA. Detection of MicroRNA in Hepatic Cirrhosis and Hepatocellular Carcinoma in Hepatitis C Genotype-4 in Egyptian Patients. Biomed Res Int 2017;2017:1806069. [PMID: 28642869 DOI: 10.1155/2017/1806069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
61 He B, He Y, Shi W, Gong S, Chen X, Xiao J, Gu J, Ding W, Wang Y. Bioinformatics analysis of gene expression alterations in microRNA‑122 knockout mice with hepatocellular carcinoma. Mol Med Rep 2017;15:3681-9. [PMID: 28393247 DOI: 10.3892/mmr.2017.6445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
62 Wahid B, Ali A, Rafique S, Idrees M. New Insights into the Epigenetics of Hepatocellular Carcinoma. Biomed Res Int 2017;2017:1609575. [PMID: 28401148 DOI: 10.1155/2017/1609575] [Cited by in Crossref: 37] [Cited by in F6Publishing: 49] [Article Influence: 7.4] [Reference Citation Analysis]
63 Xu Y, Zhang Y, Wang L, Zhao R, Qiao Y, Han D, Sun Q, Dong N, Liu Y, Wu D, Zhang X, Huang N, Ma N, Zhao W, Liu Y, Gao X. miR-200a targets Gelsolin: A novel mechanism regulating secretion of microvesicles in hepatocellular carcinoma cells. Oncol Rep 2017;37:2711-9. [PMID: 28440466 DOI: 10.3892/or.2017.5506] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
64 Huang L, Chen Y, Chen L, Xiao X, Wang X, Li J, Zhang Y. Photo-clickable microRNA for in situ fluorescence labeling and imaging of microRNA in living cells. Chem Commun 2017;53:6452-5. [DOI: 10.1039/c7cc03328a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
65 An X, Sarmiento C, Tan T, Zhu H. Regulation of multidrug resistance by microRNAs in anti-cancer therapy. Acta Pharm Sin B 2017;7:38-51. [PMID: 28119807 DOI: 10.1016/j.apsb.2016.09.002] [Cited by in Crossref: 109] [Cited by in F6Publishing: 111] [Article Influence: 21.8] [Reference Citation Analysis]
66 Mohammadi A, Mansoori B, Baradaran B. Regulation of miRNAs by herbal medicine: An emerging field in cancer therapies. Biomed Pharmacother 2017;86:262-70. [PMID: 28006752 DOI: 10.1016/j.biopha.2016.12.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
67 Li J, Huang L, Xiao X, Chen Y, Wang X, Zhou Z, Zhang C, Zhang Y. Photoclickable MicroRNA for the Intracellular Target Identification of MicroRNAs. J Am Chem Soc 2016;138:15943-9. [DOI: 10.1021/jacs.6b08521] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
68 Kumar S, Batra A, Kanthaje S, Ghosh S, Chakraborti A. Crosstalk between microRNA-122 and FOX family genes in HepG2 cells. Exp Biol Med (Maywood) 2017;242:436-40. [PMID: 27895094 DOI: 10.1177/1535370216681548] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
69 Béres NJ, Szabó D, Kocsis D, Szűcs D, Kiss Z, Müller KE, Lendvai G, Kiss A, Arató A, Sziksz E, Vannay Á, Szabó AJ, Veres G. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:327-35. [PMID: 26752469 DOI: 10.1097/MIB.0000000000000687] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
70 Bandopadhyay M, Sarkar N, Datta S, Das D, Pal A, Panigrahi R, Banerjee A, Panda CK, Das C, Chakrabarti S, Chakravarty R. Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis. Infect Agent Cancer 2016;11:40. [PMID: 27528885 DOI: 10.1186/s13027-016-0085-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
71 Rivkin M, Simerzin A, Zorde-Khvalevsky E, Chai C, Yuval JB, Rosenberg N, Harari-Steinfeld R, Schneider R, Amir G, Condiotti R, Heikenwalder M, Weber A, Schramm C, Wege H, Kluwe J, Galun E, Giladi H. Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-Derived Erythropoietin and Anemia. Gastroenterology. 2016;151:999-1010. [PMID: 27477940 DOI: 10.1053/j.gastro.2016.07.031] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
72 Wu C, Zhang J, Cao X, Yang Q, Xia D. Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression. Med Sci Monit 2016;22:2685-90. [PMID: 27472451 DOI: 10.12659/msm.896404] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
73 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
74 Sharma N, Singh SK. Implications of non-coding RNAs in viral infections. Rev Med Virol 2016;26:356-68. [PMID: 27401792 DOI: 10.1002/rmv.1893] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
75 Deddens JC, Vrijsen KR, Colijn JM, Oerlemans MI, Metz CH, van der Vlist EJ, Nolte-'t Hoen EN, den Ouden K, Jansen Of Lorkeers SJ, van der Spoel TI, Koudstaal S, Arkesteijn GJ, Wauben MH, van Laake LW, Doevendans PA, Chamuleau SA, Sluijter JP. Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury. J Cardiovasc Transl Res 2016;9:291-301. [PMID: 27383837 DOI: 10.1007/s12265-016-9705-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
76 Shyu YC, Lee TL, Lu MJ, Chen JR, Chien RN, Chen HY, Lin JF, Tsou AP, Chen YH, Hsieh CW, Huang TS. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma. J Transl Med 2016;14:200. [PMID: 27370270 DOI: 10.1186/s12967-016-0956-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
77 Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Tumour Biol. 2016;37:12273-12286. [PMID: 27271989 DOI: 10.1007/s13277-016-5097-8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 60] [Article Influence: 8.8] [Reference Citation Analysis]
78 Adlakha YK, Saini N. MicroRNA: a connecting road between apoptosis and cholesterol metabolism. Tumour Biol 2016;37:8529-54. [PMID: 27105614 DOI: 10.1007/s13277-016-4988-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
79 Lu H, Hao L, Li S, Lin S, Lv L, Chen Y, Cui H, Zi T, Chu X, Na L, Sun C. Elevated circulating stearic acid leads to a major lipotoxic effect on mouse pancreatic beta cells in hyperlipidaemia via a miR-34a-5p-mediated PERK/p53-dependent pathway. Diabetologia 2016;59:1247-57. [PMID: 26969487 DOI: 10.1007/s00125-016-3900-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
80 Li H, Jiang JD, Peng ZG. MicroRNA-mediated interactions between host and hepatitis C virus. World J Gastroenterol 2016; 22(4): 1487-1496 [PMID: 26819516 DOI: 10.3748/wjg.v22.i4.1487] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
81 Motawi TMK, Sadik NAH, Shaker OG, Ghaleb MH. Elevated serum microRNA-122/222 levels are potential diagnostic biomarkers in Egyptian patients with chronic hepatitis C but not hepatic cancer. Tumor Biol 2016;37:9865-74. [DOI: 10.1007/s13277-016-4884-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
82 He X, Li J, Guo W, Liu W, Yu J, Song W, Dong L, Wang F, Yu S, Zheng Y, Chen S, Kong Y, Liu C. Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma. Oncotarget 2015;6:2302-14. [PMID: 25544773 DOI: 10.18632/oncotarget.2955] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
83 Arora A, Singh S, Bhatt AN, Pandey S, Sandhir R, Dwarakanath BS. Interplay Between Metabolism and Oncogenic Process: Role of microRNAs. Transl Oncogenomics 2015;7:11-27. [PMID: 26740741 DOI: 10.4137/TOG.S29652] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
84 Liu N, Jiang F, He TL, Zhang JK, Zhao J, Wang C, Jiang GX, Cao LP, Kang PC, Zhong XY, Lin TY, Cui YF. The Roles of MicroRNA-122 Overexpression in Inhibiting Proliferation and Invasion and Stimulating Apoptosis of Human Cholangiocarcinoma Cells. Sci Rep 2015;5:16566. [PMID: 26686459 DOI: 10.1038/srep16566] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
85 Mizuguchi Y, Takizawa T, Yoshida H, Uchida E. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review. Hepatol Res. 2016;46:391-406. [PMID: 26490438 DOI: 10.1111/hepr.12606] [Cited by in Crossref: 65] [Cited by in F6Publishing: 74] [Article Influence: 9.3] [Reference Citation Analysis]
86 Chen R, Deng L, Yu X, Wang X, Zhu L, Yu T, Zhang Y, Zhou B, Xu W, Chen L, Luo H. MiR-122 partly mediates the ochratoxin A-induced GC-2 cell apoptosis. Toxicol In Vitro 2015;30:264-73. [PMID: 26514935 DOI: 10.1016/j.tiv.2015.10.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
87 Bronte F, Bronte G, Fanale D, Caruso S, Bronte E, Bavetta MG, Fiorentino E, Rolfo C, Bazan V, Di Marco V, Russo A. HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma. Crit Rev Oncol Hematol 2016;97:312-21. [PMID: 26603462 DOI: 10.1016/j.critrevonc.2015.09.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
88 Zhu L, Yu T, Qi X, Yang B, Shi L, Luo H, He X, Huang K, Xu W. miR-122 plays an important role in ochratoxin A-induced hepatocyte apoptosis in vitro and in vivo. Toxicol Res (Camb) 2016;5:160-7. [PMID: 30090334 DOI: 10.1039/c5tx00104h] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
89 Wang L, Yue Y, Wang X, Jin H. Function and clinical potential of microRNAs in hepatocellular carcinoma. Oncol Lett. 2015;10:3345-3353. [PMID: 26788134 DOI: 10.3892/ol.2015.3759] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
90 Lyra-González I, Flores-Fong LE, González-García I, Medina-Preciado D, Armendáriz-Borunda J. MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine. World J Hepatol 2015; 7(11): 1530-1540 [PMID: 26085912 DOI: 10.4254/wjh.v7.i11.1530] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
91 Shi Y, Huang A. Effects of sorafenib on lung metastasis in rats with hepatocellular carcinoma: the role of microRNAs. Tumor Biol 2015;36:8455-63. [DOI: 10.1007/s13277-015-3565-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
92 Nie J, Li CP. Mechanisms of microRNAs in regulation of apoptosis in non-alcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2015; 23(15): 2389-2396 [DOI: 10.11569/wcjd.v23.i15.2389] [Reference Citation Analysis]
93 Correia C, Lee SH, Meng XW, Vincelette ND, Knorr KL, Ding H, Nowakowski GS, Dai H, Kaufmann SH. Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment. Biochim Biophys Acta. 2015;1853:1658-1671. [PMID: 25827952 DOI: 10.1016/j.bbamcr.2015.03.012] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 12.0] [Reference Citation Analysis]
94 Yuan Y, Zhang Y, Liu B, Wu H, Kang Y, Li M, Zeng X, He N, Zhang G. The effects of multifunctional MiR-122-loaded graphene-gold composites on drug-resistant liver cancer. J Nanobiotechnology 2015;13:12. [PMID: 25885701 DOI: 10.1186/s12951-015-0070-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
95 Peacock O, Lee AC, Cameron F, Tarbox R, Vafadar-Isfahani N, Tufarelli C, Lund JN. Inflammation and MiR-21 pathways functionally interact to downregulate PDCD4 in colorectal cancer. PLoS One 2014;9:e110267. [PMID: 25310697 DOI: 10.1371/journal.pone.0110267] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
96 Xie KL, Zhang YG, Liu J, Zeng Y, Wu H. MicroRNAs associated with HBV infection and HBV-related HCC. Theranostics 2014;4:1176-92. [PMID: 25285167 DOI: 10.7150/thno.8715] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
97 Callegari E, Gramantieri L, Domenicali M, D’Abundo L, Sabbioni S, Negrini M. MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ. 2015;22:46-57. [PMID: 25190143 DOI: 10.1038/cdd.2014.136] [Cited by in Crossref: 85] [Cited by in F6Publishing: 101] [Article Influence: 10.6] [Reference Citation Analysis]
98 Morishita A, Masaki T. miRNA in hepatocellular carcinoma. Hepatol Res. 2015;45:128-141. [PMID: 25040738 DOI: 10.1111/hepr.12386] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 8.6] [Reference Citation Analysis]
99 Zhu Z, Zhang X, Wang G, Zheng H. Role of MicroRNAs in Hepatocellular Carcinoma. Hepat Mon. 2014;14:e18672. [PMID: 25337143 DOI: 10.5812/hepatmon.18672] [Cited by in Crossref: 33] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
100 Chen CL, Wu JC, Chen GY, Yuan PH, Tseng YW, Li KC, Hwang SM, Hu YC. Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis. Mol Ther 2015;23:79-88. [PMID: 25023326 DOI: 10.1038/mt.2014.126] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
101 Kim KM, Kim SG. Autophagy and microRNA dysregulation in liver diseases. Arch Pharm Res 2014;37:1097-116. [PMID: 25015129 DOI: 10.1007/s12272-014-0439-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
102 Chu R, Mo G, Duan Z, Huang M, Chang J, Li X, Liu P. miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression. Cell Commun Signal. 2014;12:45. [PMID: 25012758 DOI: 10.1186/s12964-014-0045-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
103 Oom AL, Humphries BA, Yang C. MicroRNAs: novel players in cancer diagnosis and therapies. Biomed Res Int 2014;2014:959461. [PMID: 25101302 DOI: 10.1155/2014/959461] [Cited by in Crossref: 33] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
104 Wang G, Zhao Y, Zheng Y. miR-122/Wnt/β-catenin regulatory circuitry sustains glioma progression. Tumor Biol 2014;35:8565-72. [DOI: 10.1007/s13277-014-2089-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
105 D'Anzeo M, Faloppi L, Scartozzi M, Giampieri R, Bianconi M, Del Prete M, Silvestris N, Cascinu S. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. Molecules. 2014;19:6393-6406. [PMID: 24853455 DOI: 10.3390/molecules19056393] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
106 Basu S, Bhattacharyya SN. Insulin-like growth factor-1 prevents miR-122 production in neighbouring cells to curtail its intercellular transfer to ensure proliferation of human hepatoma cells. Nucleic Acids Res. 2014;42:7170-7185. [PMID: 24813441 DOI: 10.1093/nar/gku346] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 7.5] [Reference Citation Analysis]
107 Androsavich JR, Chau BN. Non-inhibited miRNAs shape the cellular response to anti-miR. Nucleic Acids Res 2014;42:6945-55. [PMID: 24810853 DOI: 10.1093/nar/gku344] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
108 Hung CH, Chiu YC, Chen CH, Hu TH. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. Biomed Res Int. 2014;2014:486407. [PMID: 24800233 DOI: 10.1155/2014/486407] [Cited by in Crossref: 37] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
109 Peng F, Xiao X, Jiang Y, Luo K, Tian Y, Peng M, Zhang M, Xu Y, Gong G. HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122. PLoS One. 2014;9:e92998. [PMID: 24667324 DOI: 10.1371/journal.pone.0092998] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
110 Wang C, Ren R, Hu H, Tan C, Han M, Wang X, Zheng Y. MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma. Chin J Cancer Res 2014;26:17-29. [PMID: 24653623 DOI: 10.3978/j.issn.1000-9604.2014.01.01] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
111 Valencia-Quintana R, Sánchez-Alarcón J, Tenorio-Arvide MG, Deng Y, Montiel-González JM, Gómez-Arroyo S, Villalobos-Pietrini R, Cortés-Eslava J, Flores-Márquez AR, Arenas-Huertero F. The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review. Front Microbiol 2014;5:102. [PMID: 24672518 DOI: 10.3389/fmicb.2014.00102] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
112 Genini S, Guziewicz KE, Beltran WA, Aguirre GD. Altered miRNA expression in canine retinas during normal development and in models of retinal degeneration. BMC Genomics 2014;15:172. [PMID: 24581223 DOI: 10.1186/1471-2164-15-172] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
113 Nakao K, Miyaaki H, Ichikawa T. Antitumor function of microRNA-122 against hepatocellular carcinoma. J Gastroenterol. 2014;49:589-593. [PMID: 24531873 DOI: 10.1007/s00535-014-0932-4] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 9.9] [Reference Citation Analysis]
114 Turato C, Simonato D, Quarta S, Gatta A, Pontisso P. MicroRNAs and SerpinB3 in hepatocellular carcinoma. Life Sci. 2014;100:9-17. [PMID: 24496037 DOI: 10.1016/j.lfs.2014.01.073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
115 Li X, Yang W, Lou L, Chen Y, Wu S, Ding G. microRNA: a promising diagnostic biomarker and therapeutic target for hepatocellular carcinoma. Dig Dis Sci. 2014;59:1099-1107. [PMID: 24390674 DOI: 10.1007/s10620-013-3006-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
116 Frau M, Feo CF, Feo F, Pascale RM. New insights on the role of epigenetic alterations in hepatocellular carcinoma. J Hepatocell Carcinoma 2014;1:65-83. [PMID: 27508177 DOI: 10.2147/JHC.S44506] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Qiu Z, Dai Y. Roadmap of miR-122-related clinical application from bench to bedside. Expert Opin Investig Drugs 2014;23:347-55. [PMID: 24354366 DOI: 10.1517/13543784.2014.867327] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
118 Borel F, Kay MA, Mueller C. Recombinant AAV as a platform for translating the therapeutic potential of RNA interference. Mol Ther 2014;22:692-701. [PMID: 24352214 DOI: 10.1038/mt.2013.285] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 8.4] [Reference Citation Analysis]
119 Ruoquan Y, Wanpin N, Qiangsheng X, Guodong T, Feizhou H. Correlation between plasma miR-122 expression and liver injury induced by hepatectomy. J Int Med Res 2014;42:77-84. [PMID: 24287929 DOI: 10.1177/0300060513499093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
120 Guicciardi ME, Malhi H, Mott JL, Gores GJ. Apoptosis and necrosis in the liver. Compr Physiol. 2013;3:977-1010. [PMID: 23720337 DOI: 10.1002/cphy.c120020] [Cited by in Crossref: 50] [Cited by in F6Publishing: 136] [Article Influence: 5.6] [Reference Citation Analysis]
121 Aluru N, Deak KL, Jenny MJ, Hahn ME. Developmental exposure to valproic acid alters the expression of microRNAs involved in neurodevelopment in zebrafish. Neurotoxicol Teratol 2013;40:46-58. [PMID: 24126255 DOI: 10.1016/j.ntt.2013.10.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
122 Wang X, Yu B, Ren W, Mo X, Zhou C, He H, Jia H, Wang L, Jacob ST, Lee RJ, Ghoshal K, Lee LJ. Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations. J Control Release 2013;172:690-8. [PMID: 24121065 DOI: 10.1016/j.jconrel.2013.09.027] [Cited by in Crossref: 47] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
123 Khare S, Zhang Q, Ibdah JA. Epigenetics of hepatocellular carcinoma: Role of microRNA. World J Gastroenterol 2013; 19(33): 5439-5445 [PMID: 24023486 DOI: 10.3748/wjg.v19.i33.5439] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
124 Callegari E, Elamin BK, Sabbioni S, Gramantieri L, Negrini M. Role of microRNAs in hepatocellular carcinoma: a clinical perspective. Onco Targets Ther. 2013;6:1167-1178. [PMID: 24039437 DOI: 10.2147/ott.s36161] [Cited by in Crossref: 19] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
125 Greene CM, Varley RB, Lawless MW. MicroRNAs and liver cancer associated with iron overload: Therapeutic targets unravelled. World J Gastroenterol 2013; 19(32): 5212-5226 [PMID: 23983424 DOI: 10.3748/wjg.v19.i32.5212] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
126 Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma. J Gastroenterol Hepatol. 2013;28:565-575. [PMID: 22989374 DOI: 10.1111/j.1440-1746.2012.07271.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 76] [Article Influence: 7.8] [Reference Citation Analysis]
127 Deddens JC, Colijn JM, Oerlemans MI, Pasterkamp G, Chamuleau SA, Doevendans PA, Sluijter JP. Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome. J Cardiovasc Transl Res 2013;6:884-98. [PMID: 23897095 DOI: 10.1007/s12265-013-9493-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
128 Koh YS, Kim JH, Cai H, Li L, Kim H, Kim K, Kim N, Shin BA, Lee T, Choi S, Cho CK. Dysregulated microRNAs in non-cirrhotic hepatocellular carcinoma. Genes Genom 2013;35:759-65. [DOI: 10.1007/s13258-013-0126-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
129 Saito Y, Hibino S, Saito H. Alterations of epigenetics and microRNA in hepatocellular carcinoma. Hepatol Res 2014;44:31-42. [PMID: 23617364 DOI: 10.1111/hepr.12147] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
130 Aravalli RN. Development of microRNA therapeutics for hepatocellular carcinoma. Diagnostics. 2013;3:170-191. [PMID: 26835673 DOI: 10.3390/diagnostics3010170] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
131 Calvisi DF, Frau M, Tomasi ML, Feo F, Pascale RM. Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: novel insights from interspecies comparison. Biochim Biophys Acta 2012;1826:215-37. [PMID: 23393659 DOI: 10.1016/j.bbcan.2012.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 23] [Article Influence: 0.6] [Reference Citation Analysis]
132 Köberle V, Waidmann O, Kronenberger B, Andrei A, Susser S, Füller C, Perner D, Zeuzem S, Sarrazin C, Piiper A. Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy. J Viral Hepat. 2013;20:530-535. [PMID: 23808991 DOI: 10.1111/jvh.12075] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
133 Sun J, Lu H, Wang X, Jin H. MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. ScientificWorldJournal 2013;2013:924206. [PMID: 23431261 DOI: 10.1155/2013/924206] [Cited by in Crossref: 37] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
134 Li A, Song W, Qian J, Li Y, He J, Zhang Q, Li W, Zhai A, Kao W, Hu Y, Li H, Wu J, Ling H, Zhong Z, Zhang F. MiR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1. Int J Biochem Cell Biol 2013;45:858-65. [PMID: 23348614 DOI: 10.1016/j.biocel.2013.01.008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
135 Wang F, Liu M, Li X, Tang H. MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett 2013;587:488-95. [PMID: 23337879 DOI: 10.1016/j.febslet.2013.01.016] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 10.1] [Reference Citation Analysis]
136 Thibault PA, Huys A, Dhillon P, Wilson JA. MicroRNA-122-dependent and -independent replication of Hepatitis C Virus in Hep3B human hepatoma cells. Virology 2013;436:179-90. [PMID: 23245472 DOI: 10.1016/j.virol.2012.11.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
137 Li J, Ghazwani M, Zhang Y, Lu J, Li J, Fan J, Gandhi CR, Li S. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol. 2013;58:522-528. [PMID: 23178710 DOI: 10.1016/j.jhep.2012.11.011] [Cited by in Crossref: 119] [Cited by in F6Publishing: 125] [Article Influence: 11.9] [Reference Citation Analysis]
138 Li J, Ghazwani M, Zhang Y, Lu J, Li J, Fan J, Gandhi CR, Li S. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol. 2013;58:522-528. [PMID: 23178710 DOI: 10.1016/j.jhep.2012.11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Li W, Lebrun DG, Li M. The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma. Chin J Cancer. 2011;30:540-550. [PMID: 21801602 DOI: 10.5732/cjc.011.10197] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
140 Mo MH, Chen L, Fu Y, Wang W, Fu SW. Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer. 2012;3:432-448. [PMID: 23074383 DOI: 10.7150/jca.4919] [Cited by in Crossref: 93] [Cited by in F6Publishing: 98] [Article Influence: 9.3] [Reference Citation Analysis]
141 Cutting AD, Bannister SC, Doran TJ, Sinclair AH, Tizard MV, Smith CA. The potential role of microRNAs in regulating gonadal sex differentiation in the chicken embryo. Chromosome Res 2012;20:201-13. [PMID: 22161018 DOI: 10.1007/s10577-011-9263-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
142 Singhal A, Jayaraman M, Dhanasekaran DN, Kohli V. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012;82:116-40. [DOI: 10.1016/j.critrevonc.2011.05.005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
143 Zhang Q, Pu R, Du Y, Han Y, Su T, Wang H, Cao G. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets. Cancer Lett. 2012;321:1-12. [PMID: 22425745 DOI: 10.1016/j.canlet.2012.03.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
144 Connelly CM, Thomas M, Deiters A. High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function. J Biomol Screen. 2012;17:822-828. [PMID: 22412086 DOI: 10.1177/1087057112439606] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
145 Borel F, Konstantinova P, Jansen PL. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J Hepatol. 2012;56:1371-1383. [PMID: 22314424 DOI: 10.1016/j.jhep.2011.11.026] [Cited by in Crossref: 157] [Cited by in F6Publishing: 160] [Article Influence: 15.7] [Reference Citation Analysis]
146 Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, Wu F. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway. Liver Int 2012;32:752-60. [DOI: 10.1111/j.1478-3231.2011.02750.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 147] [Article Influence: 15.1] [Reference Citation Analysis]
147 Shen L, Li J, Xu L, Ma J, Li H, Xiao X, Zhao J, Fang L. miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w. Exp Ther Med 2012;3:475-80. [PMID: 22969914 DOI: 10.3892/etm.2011.428] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 6.6] [Reference Citation Analysis]
148 Elamin BK, Callegari E, Gramantieri L, Sabbioni S, Negrini M. MicroRNA response to environmental mutagens in liver. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2011;717:67-76. [DOI: 10.1016/j.mrfmmm.2011.03.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
149 Waidmann O, Bihrer V, Pleli T, Farnik H, Berger A, Zeuzem S, Kronenberger B, Piiper A. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat. 2012;19:e58-e65. [PMID: 22239527 DOI: 10.1111/j.1365-2893.2011.01536.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 7.7] [Reference Citation Analysis]
150 Li S, Zhu J, Fu H, Wan J, Hu Z, Liu S, Li J, Tie Y, Xing R, Zhu J, Sun Z, Zheng X. Hepato-specific microRNA-122 facilitates accumulation of newly synthesized miRNA through regulating PRKRA. Nucleic Acids Res 2012;40:884-91. [PMID: 21937511 DOI: 10.1093/nar/gkr715] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
151 Saito Y, Suzuki H, Matsuura M, Sato A, Kasai Y, Yamada K, Saito H, Hibi T. MicroRNAs in Hepatobiliary and Pancreatic Cancers. Front Genet. 2011;2:66. [PMID: 22303361 DOI: 10.3389/fgene.2011.00066] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
152 McDermott AM, Heneghan HM, Miller N, Kerin MJ. The therapeutic potential of microRNAs: disease modulators and drug targets. Pharm Res 2011;28:3016-29. [PMID: 21818713 DOI: 10.1007/s11095-011-0550-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
153 Zhang G, Wang Q, Xu R. Therapeutics Based on microRNA: A New Approach for Liver Cancer. Curr Genomics 2010;11:311-25. [PMID: 21286309 DOI: 10.2174/138920210791616671] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
154 Sayed D, Abdellatif M. MicroRNAs in Development and Disease. Physiological Reviews 2011;91:827-87. [DOI: 10.1152/physrev.00006.2010] [Cited by in Crossref: 691] [Cited by in F6Publishing: 700] [Article Influence: 62.8] [Reference Citation Analysis]
155 Xu Y, Xia F, Ma L, Shan J, Shen J, Yang Z, Liu J, Cui Y, Bian X, Bie P, Qian C. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Cancer Letters 2011. [DOI: 10.1016/j.canlet.2011.06.027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 101] [Article Influence: 2.0] [Reference Citation Analysis]
156 Her GM, Hsu CC, Hong JR, Lai CY, Hsu MC, Pang HW, Chan SK, Pai WY. Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio). Biochim Biophys Acta. 2011;1811:536-548. [PMID: 21722753 DOI: 10.1016/j.bbalip.2011.06.011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
157 Law PT, Wong N. Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26:437-449. [PMID: 21332540 DOI: 10.1111/j.1440-1746.2010.06512.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
158 Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, Peveling-Oberhag J, Radeke HH, Sarrazin C, Herrmann E, Zeuzem S, Waidmann O, Piiper A. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2011;106:1663-9. [PMID: 21606975 DOI: 10.1038/ajg.2011.161] [Cited by in Crossref: 138] [Cited by in F6Publishing: 135] [Article Influence: 12.5] [Reference Citation Analysis]
159 Starlard-Davenport A, Tryndyak V, Kosyk O, Ross SR, Rusyn I, Beland FA, Pogribny IP. Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis. J Nutrigenet Nutrigenomics 2010;3:259-66. [PMID: 21474957 DOI: 10.1159/000324362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
160 Burchard J, Zhang C, Liu AM, Poon RT, Lee NP, Wong KF, Sham PC, Lam BY, Ferguson MD, Tokiwa G, Smith R, Leeson B, Beard R, Lamb JR, Lim L, Mao M, Dai H, Luk JM. microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol. 2010;6:402. [PMID: 20739924 DOI: 10.1038/msb.2010.58] [Cited by in Crossref: 126] [Cited by in F6Publishing: 135] [Article Influence: 11.5] [Reference Citation Analysis]
161 Albulescu R, Neagu M, Albulescu L, Tanase C. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers. Expert Rev Mol Diagn. 2011;11:101-120. [PMID: 21171925 DOI: 10.1586/erm.10.106] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
162 Diao S, Zhang JF, Wang H, He ML, Lin MC, Chen Y, Kung HF. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma. Proteomics. 2010;10:3723-3731. [PMID: 20859956 DOI: 10.1002/pmic.201000050] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
163 Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu D, Huang Y. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J 2011;278:786-92. [PMID: 21205209 DOI: 10.1111/j.1742-4658.2010.07997.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 6.5] [Reference Citation Analysis]
164 Lima RT, Busacca S, Almeida GM, Gaudino G, Fennell DA, Vasconcelos MH. MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer. 2011;47:163-174. [PMID: 21145728 DOI: 10.1016/j.ejca.2010.11.005] [Cited by in Crossref: 177] [Cited by in F6Publishing: 181] [Article Influence: 14.8] [Reference Citation Analysis]
165 Huang S, He X. The role of microRNAs in liver cancer progression. Br J Cancer. 2011;104:235-240. [PMID: 21102580 DOI: 10.1038/sj.bjc.6606010] [Cited by in Crossref: 158] [Cited by in F6Publishing: 164] [Article Influence: 13.2] [Reference Citation Analysis]
166 Gao P, Wong CC, Tung EK, Lee JM, Wong CM, Ng IO. Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J Hepatol. 2011;54:1177-1184. [PMID: 21145831 DOI: 10.1016/j.jhep.2010.09.023] [Cited by in Crossref: 100] [Cited by in F6Publishing: 105] [Article Influence: 8.3] [Reference Citation Analysis]
167 Song B, Ju J. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis. Expert Rev Mol Med 2010;12:e33. [PMID: 20942990 DOI: 10.1017/S1462399410001663] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
168 Xu H, He JH, Xiao ZD, Zhang QQ, Chen YQ, Zhou H, Qu LH. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology 2010;52:1431-42. [PMID: 20842632 DOI: 10.1002/hep.23818] [Cited by in Crossref: 194] [Cited by in F6Publishing: 201] [Article Influence: 16.2] [Reference Citation Analysis]
169 Banerjee A, Ray RB, Ray R. Oncogenic potential of hepatitis C virus proteins. Viruses. 2010;2:2108-2133. [PMID: 21994721 DOI: 10.3390/v2092108] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 6.3] [Reference Citation Analysis]
170 Young DD, Connelly CM, Grohmann C, Deiters A. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J Am Chem Soc. 2010;132:7976-7981. [PMID: 20527935 DOI: 10.1021/ja910275u] [Cited by in Crossref: 189] [Cited by in F6Publishing: 187] [Article Influence: 15.8] [Reference Citation Analysis]
171 Wu X, Wu S, Tong L, Luan T, Lin L, Lu S, Zhao W, Ma Q, Liu H, Zhong Z. miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells. Scand J Gastroenterol 2009;44:1332-9. [PMID: 19891584 DOI: 10.3109/00365520903215305] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
172 Li Q, Wang G, Shan JL, Yang ZX, Wang HZ, Feng J, Zhen JJ, Chen C, Zhang ZM, Xu W. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J Gastroenterol Hepatol. 2010;25:164-171. [PMID: 19793168 DOI: 10.1111/j.1440-1746.2009.05971.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
173 Mott JL. MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia. Hepatology 2009;50:630-7. [PMID: 19585622 DOI: 10.1002/hep.23010] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 5.8] [Reference Citation Analysis]
174 Garofalo M, Condorelli GL, Croce CM, Condorelli G. MicroRNAs as regulators of death receptors signaling. Cell Death Differ 2010;17:200-8. [PMID: 19644509 DOI: 10.1038/cdd.2009.105] [Cited by in Crossref: 69] [Cited by in F6Publishing: 87] [Article Influence: 5.3] [Reference Citation Analysis]
175 Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene. 2009;28:3526-3536. [PMID: 19617899 DOI: 10.1038/onc.2009.211] [Cited by in Crossref: 484] [Cited by in F6Publishing: 495] [Article Influence: 37.2] [Reference Citation Analysis]
176 Wang X, Lam EK, Zhang J, Jin H, Sung JJ. MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers. Biochem Biophys Res Commun. 2009;387:376-380. [PMID: 19607815 DOI: 10.1016/j.bbrc.2009.07.034] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
177 Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, Hsu MT, Hsiao M, Huang HD, Tsou AP. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2009;49:1571-82. [PMID: 19296470 DOI: 10.1002/hep.22806] [Cited by in Crossref: 438] [Cited by in F6Publishing: 420] [Article Influence: 33.7] [Reference Citation Analysis]
178 Padgett KA, Lan RY, Leung PC, Lleo A, Dawson K, Pfeiff J, Mao TK, Coppel RL, Ansari AA, Gershwin ME. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun. 2009;32:246-253. [PMID: 19345069 DOI: 10.1016/j.jaut.2009.02.022] [Cited by in Crossref: 147] [Cited by in F6Publishing: 147] [Article Influence: 11.3] [Reference Citation Analysis]